1. Volume 73, Issue 2, Pages 226-232 (February 2018)
Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non– muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in patients 
Judith Bosschieter, Jakko A. Nieuwenhuijzen, Tessa van Ginkel, André N. Vis, Birgit Witte, Don Newling, Goedele M.A. Beckers, R. Jeroen A. van Moorselaar 
European Urology 
Volume 73, Issue 2, Pages (February 2018)
DOI: /j.eururo
Copyright © 2017 European Association of Urology Terms and Conditions

2. Fig. 1
Flowchart of all randomised patients. Group A=low-risk group, immediate instillation; group B=low-risk group, delayed instillation; group C=intermediate-risk group, immediate instillation; Group D=intermediate risk group, delayed instillation; group E=high-risk group, immediate instillation; and group F=high-risk group, delayed instillation. MIBC=muscle-invasive bladder cancer; TURBT=transurethral resection of the bladder tumour; FU=follow-up.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions

3. Fig. 2
Kaplan–Meier curve showing the recurrence-free survival for all patients in the immediate and delayed intravesical instillation groups.
European Urology  , DOI: ( /j.eururo )
Copyright © 2017 European Association of Urology Terms and Conditions